IL139072A0 - Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine - Google Patents

Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Info

Publication number: IL139072A0
Authority: IL; Israel
Prior art keywords: acetylglucosamine; treatment; composition; inflammatory bowel; bowel disease
Prior art date: 1998-04-17

Application number

IL13907299A

Other languages

English (en)

Original Assignee

Glucogenics Pharmaceuticals In

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-17

Filing date

1999-03-12

Publication date

2001-11-25

1999-03-12 Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In

1999-03-12 Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/en

2001-11-25 Publication of IL139072A0 publication Critical patent/IL139072A0/xx

Links

208000022559 Inflammatory bowel disease Diseases 0.000 title 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 title 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 title 1
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 title 1
210000001072 colon Anatomy 0.000 title 1
229950006780 n-acetylglucosamine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

IL13907299A 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine IL139072A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002234936A CA2234936C (en)	1998-04-17	1998-04-17	Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (en)	1998-04-17	1999-03-12	Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (1)

Publication Number	Publication Date
IL139072A0 true IL139072A0 (en)	2001-11-25

Family

ID=4162337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13907299A IL139072A0 (en)	1998-04-17	1999-03-12	Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Country Status (8)

Country	Link
EP (1)	EP1071432A1 (cs)
JP (1)	JP2002512195A (cs)
CA (1)	CA2234936C (cs)
CZ (1)	CZ20003846A3 (cs)
HU (1)	HUP0101514A3 (cs)
IL (1)	IL139072A0 (cs)
NO (1)	NO20005223L (cs)
PL (1)	PL343634A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2552842T3 (es)	2007-02-19	2015-12-02	Marine Polymer Technologies, Inc.	Composiciones hemostáticas y regímenes terapéuticos
KR101098581B1 (ko)	2009-01-09	2011-12-26	서울대학교산학협력단	Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
AU2011239466B2 (en)	2010-04-15	2015-01-22	Marine Polymer Technologies, Inc.	Anti-bacterial applications of poly -N-acetylglucosamine nanofibers
MX356877B (es)	2011-04-15	2018-06-19	Marine Polymer Tech Inc	Tratamiento de enfermedades con nanofibras de poli-n-acetil-glucosamina.
WO2014142938A1 (en) *	2013-03-15	2014-09-18	Aihol Corporation	Pharmaceutical formulation containing glycosaminoglycan
US9539265B2 (en)	2013-03-15	2017-01-10	Aihol Corporation	Pharmaceutical formulation containing glycosaminoglycan
KR20170086044A (ko) *	2014-11-26	2017-07-25	에보니크 룀 게엠베하	에탄올의 영향에 대해 내성을 갖는 의약품 또는 영양보조식품 조성물
KR102104507B1 (ko) *	2019-08-23	2020-04-24	브릿지바이오테라퓨틱스(주)	팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

1998
- 1998-04-17 CA CA002234936A patent/CA2234936C/en not_active Expired - Fee Related
1999
- 1999-03-12 CZ CZ20003846A patent/CZ20003846A3/cs unknown
- 1999-03-12 JP JP2000544333A patent/JP2002512195A/ja active Pending
- 1999-03-12 IL IL13907299A patent/IL139072A0/xx unknown
- 1999-03-12 PL PL99343634A patent/PL343634A1/xx unknown
- 1999-03-12 HU HU0101514A patent/HUP0101514A3/hu unknown
- 1999-03-12 EP EP99907220A patent/EP1071432A1/en not_active Withdrawn
2000
- 2000-10-17 NO NO20005223A patent/NO20005223L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2234936A1 (en)	1999-10-17
HUP0101514A3 (en)	2003-07-28
CZ20003846A3 (cs)	2002-03-13
HUP0101514A2 (hu)	2001-11-28
JP2002512195A (ja)	2002-04-23
CA2234936C (en)	2004-06-29
PL343634A1 (en)	2001-08-27
NO20005223D0 (no)	2000-10-17
NO20005223L (no)	2000-11-20
EP1071432A1 (en)	2001-01-31

Similar Documents

Publication	Publication Date	Title
IL132145A (en)	2005-11-20	Compositions for treating inflammatory bowel disease and uses thereof
HUP9900950A3 (en)	2000-01-28	Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease
IL142929A0 (en)	2002-04-21	Local delivery of drugs to the colon for local treatment of colonic diseases
WO2003034984A9 (en)	2011-01-20	Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
NO20022974D0 (no)	2002-06-20	Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
IL138032A0 (en)	2001-10-31	Pharmaceutical composition of topiramate
EP0808324A4 (en)	2002-03-13	COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES
EP1119255A4 (en)	2009-04-15	NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES
AU1917201A (en)	2001-05-30	Amide therapeutics and methods for treating inflammatory bowel disease
AU2027595A (en)	1995-12-07	Pharmaceutical composition for treating inflammatory bowel diseases
ZA988920B (en)	1999-06-09	Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
AU2002246519A8 (en)	2005-09-15	Compositions and methods for the therapy and diagnosis of colon cancer
AU6386499A (en)	2000-04-10	Method and composition for treatment of inflammatory bowel disease
PL343634A1 (en)	2001-08-27	Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
EP1085906A4 (en)	2002-02-06	ANTIBODIES AGAINST CYTOKINS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
IL147946A0 (en)	2002-08-14	Treatment of inflammatory or malignant disease using dnazymes
AU2001257406A1 (en)	2001-11-07	Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
HUP9900309A3 (en)	1999-11-29	Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
IL121096A0 (en)	1997-11-20	Pharmaceutical compositions for the treatment of liver disease
EP1107778A4 (en)	2003-07-02	TREATMENT OF DISEASE CONDITIONS
HUP0000569A3 (en)	2000-11-28	Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
GB9725346D0 (en)	1998-01-28	Pharmaceutical composition for the treatment of inflammatory bowel disease
AU7470794A (en)	1995-12-21	2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
GB9701041D0 (en)	1997-03-05	Treatment of inflammatory bowel conditions
AUPO594097A0 (en)	1997-04-24	Novel methods of treating inflammatory bowel disease